ArticleJournal of synchrotron radiation2026
FaXToR: the hard X-ray micro-tomography beamline at the Spanish synchrotron ALBA.
Article in Journal of synchrotron radiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
FaXToR is the first hard X-ray imaging beamline built and commissioned at the Spanish synchrotron light source ALBA, and therefore the start of user operation marks the introduction of a new imaging user community to the facility. FaXToR has pushed the implementation of a multi-scale, multimodal approach to investigate the morpho-structural changes of a number of materials within a range of applications, including biomedicine, material science, cultural heritage and paleontology. In this work, we describe the FaXToR beamline optical layout and the beam properties and we provide details on the flexible in-house design of the endstation. Beamline commissioning results are presented as well. Finally, an overview of its main applications is provided, defining the main strategic program the beamline will develop during its lifetime.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.